Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.99 is 34% below its 5-year average of 1.49, near the low end of its 5-year range (0.34–3.44).
As of the fiscal period ended Tuesday, June 30, 2026. 5.43% above its 12-month average of 0.94.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.99.
CURRENT RATIO
0.99
CURRENT RATIO AVG TTM
0.94
CURRENT RATIO AVG 3Y
0.96
CURRENT RATIO AVG 5Y
1.49
CURRENT RATIO AVG 10Y
1.75
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.43%
CURRENT VS 3Y AVG
+3.07%
CURRENT VS 5Y AVG
-33.92%
CURRENT VS 10Y AVG
-43.53%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-73.71%
vs the sector median at left
Market Cap
$12.44M
Current Ratio
0.66
TTM Avg
2.17
3Y Avg
2.40
5Y Avg
3.73
Market Cap
$12.58M
Current Ratio
0.38
TTM Avg
2.35
3Y Avg
3.38
5Y Avg
3.85
Market Cap
$12.78M
Current Ratio
10.57
TTM Avg
6.64
3Y Avg
7.08
5Y Avg
4.73
Market Cap
$12.06M
Current Ratio
6.66
TTM Avg
2.77
3Y Avg
1.93
5Y Avg
5.53
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | $12.48M | 0.99 | 0.94 | 0.96 | 1.49 |
| Cytosorbents Corporation (CTSO)vs › | $12.44M | 0.66 | 2.17 | 2.40 | 3.73 |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | 0.38 | 2.35 | 3.38 | 3.85 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | 10.57 | 6.64 | 7.08 | 4.73 |
| Lantern Pharma Inc. (LTRN)vs › | $12.17M | 1.96 | 4.12 | 11.35 | 18.88 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.06M | 6.66 | 2.77 | 1.93 | 5.53 |
| Biofrontera Inc. (BFRI)vs › | $11.93M | 1.18 | 1.62 | 1.65 | 2.40 |
| Passage Bio, Inc. (PASG)vs › | $13.11M | 1.22 | 3.07 | 6.03 | 8.35 |
| IRIDEX Corporation (IRIX)vs › | $11.77M | 1.82 | 1.91 | 1.82 | 2.33 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | 0.84 | 0.51 | 4.20 | 6.42 |
Current Ratio
0.99
Quick Ratio
0.99
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.99 |
| 2026-03-31 | 1.03 |
| 2025-12-31 | 1.14 |
| 2025-09-30 | 1.18 |
| 2025-06-30 | 0.34 |
| 2025-03-31 | 0.56 |
| 2024-12-31 | 0.85 |
| 2024-09-30 | 1.14 |
| 2024-06-30 | 1.43 |
| 2024-03-31 | 0.56 |
| 2023-12-31 | 0.86 |
| 2023-09-30 | 0.85 |
| 2023-06-30 | 0.90 |
| 2023-03-31 | 1.21 |
| 2022-12-31 | 1.36 |
| 2022-09-30 | 2.17 |
| 2022-06-30 | 3.03 |
| 2022-03-31 | 2.92 |
| 2021-12-31 | 3.44 |
| 2021-09-30 | 3.03 |
| 2021-06-30 | 2.34 |
| 2021-03-31 | 1.57 |
| 2020-12-31 | 0.91 |
| 2020-09-30 | 0.88 |
| 2020-06-30 | 1.28 |
| 2020-03-31 | 1.98 |
| 2019-12-31 | 1.15 |
| 2019-09-30 | 1.72 |
| 2019-06-30 | 3.32 |
| 2019-03-31 | 4.19 |
| 2018-12-31 | 6.64 |
| 2018-09-30 | 8.45 |
| 2018-06-30 | 10.13 |
| 2018-03-31 | 19.74 |
| 2017-12-31 | 8.64 |
| 2017-09-30 | 12.37 |
| 2017-06-30 | 2.43 |
| 2017-03-31 | 2.34 |
| 2016-12-31 | 2.17 |
| 2016-09-30 | 2.47 |
| 2016-06-30 | 3.38 |
| 2016-03-31 | 3.99 |
| 2015-12-31 | 4.73 |
| 2015-09-30 | 7.46 |
| 2015-06-30 | 11.10 |
| 2015-03-31 | 11.08 |
| 2014-12-31 | 6.55 |
| 2014-09-30 | 9.36 |
| 2014-06-30 | 10.97 |
| 2014-03-31 | 0.48 |
| 2013-12-31 | 1.06 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
